Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.44 |
| ▸ | TNFSF10 | P50591 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6173020 | 0.95 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1MEN1KMT2AKDM4E | |
| SCHEMBL15840247 | 0.92 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MEN1KMT2AKDM4E | |
| SCHEMBL25852245 | 0.90 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1MEN1KMT2AKDM4E | |
| SCHEMBL9189662 | 0.87 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MEN1KMT2AKDM4E | |
| SCHEMBL6111135 | 0.87 | L3MBTL1 (0.52) | ALDH1A1L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL11810896 | 0.87 | L3MBTL1 (0.52) | ALDH1A1L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL23624497 | 0.86 | NR1H4 (0.63) | ALDH1A1MEN1KMT2AKDM4EHPGD | |
| SCHEMBL15025989 | 0.85 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL13231717 | 0.85 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL2879894 | 0.85 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119530850-A | Controllable growth of sp on multiple substrates2Method for preparing carbon conjugated 2D COFs film | 首都师范大学 | 2025-02-28 | — | — | CN | claimed |
| EP-3981762-B1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2025-10-15 | — | — | EP | disclosed |
| US-12410151-B2 | Fluorene derivative and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2025-09-09 | — | — | US | disclosed |
| CN-120040354-A | Telmisartan intermediate intermediate and preparation method thereof | 复星万邦(江苏)医药集团有限公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-4491695-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | Samsung Display Co., Ltd. (KR) | 2025-01-15 | — | — | EP | disclosed |
| CN-119285616-A | Light-emitting material, light-emitting device, electronic apparatus, and electronic device | 三星显示有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20240292745-A1 | FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2024-08-29 | — | — | US | disclosed |
| EP-4063368-B1 | NITROGEN-CONTAINING COMPOUND AND ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2024-06-26 | — | — | EP | disclosed |
| US-12010911-B2 | Fluorene derivative and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2024-06-11 | — | — | US | disclosed |
| US-20240074308-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| US-5684070-A | FILM WITH TRIAZINE RESORCINOL COMPOUND STABILIZERS FOR RADIATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1997-11-04 | — | — | US | disclosed |
| US-5681955-A | PHOTOSTABILITY OF POLYMERS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1997-10-28 | — | — | US | disclosed |
| US-5675004-A | POLYMER STABILIZERS TO PROTECT AGAINST ACTINIC RADIATION COVERING MORE OF THE NEAR-UV SPECTRUM; DISCOLORATION INHIBITION; SYNERGISTIC EFFECT WITH HINDERED AMINES; ALKYD, ACRYLIC, URETHANE COATINGS | CIBA-GEIGY CORPORATION (US) | 1997-10-07 | — | — | US | disclosed |
| US-5648488-A | Compositions stabilized with red-shifted tris-aryl-s-triazines | CIBA-GEIGY CORPORATION (US) | 1997-07-15 | — | — | US | disclosed |
| US-5637706-A | ACTINIC RADIATION STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1997-06-10 | — | — | US | disclosed |
| US-5556973-A | Red-shifted tris-aryl-s-triazines and compositions stabilized therewith | CIBA-GEIGY CORPORATION (US) | 1996-09-17 | — | — | US | disclosed |
| US-5543518-A | ALKYLATION OF TRIS-ARYL-S-TRIAZINE COMPOUNDS WITH ALKENES, CYCLOALKENES, PHENYLALKENES | CIBA-GEIGY CORPORATION (US) | 1996-08-06 | — | — | US | disclosed |
| EP-0704437-A2 | Red-shifted tris-aryl-s-triazines and compositions stabilized therewith | CIBA-GEIGY AG (CH) | 1996-04-03 | — | — | EP | disclosed |
| US-5438138-A | Process for the preparation of mono- and diaryltriazines | CIBA-GEIGY CORPORATION (US) | 1995-08-01 | — | — | US | disclosed |
| EP-0577559-A2 | Process for the preparation of mono- and diaryltriazines | CIBA-GEIGY AG (CH) | 1994-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12010911-B2 | Fluorene derivative and organic light emitting device comprising same | CRY1, CRY2, LEF1 | ALDH1A1 9/4885L3MBTL1 2155/4885MEN1 356/4885 |
| US-12410151-B2 | Fluorene derivative and organic light emitting device comprising same | LAS1L, ARL1, UBE2L3 | ALDH1A1 591/4885L3MBTL1 196/4885MEN1 794/4885 |
| US-20240292745-A1 | FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | AFF1, FLI1, CRY1 | ALDH1A1 10/4885L3MBTL1 1135/4885MEN1 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.